Cargando…

Living Donor Kidney Transplantation Should Be Promoted Among “Elderly” Patients

Age criteria for kidney transplantation have been liberalized over the years resulting in more waitlisted elderly patients. What are the prospects of elderly patients on the waiting list? METHODS. Between 2000 and 2013, 2622 patients had been waitlisted. Waiting time was defined as the period betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Laging, Mirjam, Kal-van Gestel, Judith A., Weimar, Willem, Roodnat, Joke I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791595/
https://www.ncbi.nlm.nih.gov/pubmed/31723590
http://dx.doi.org/10.1097/TXD.0000000000000940
_version_ 1783459006493229056
author Laging, Mirjam
Kal-van Gestel, Judith A.
Weimar, Willem
Roodnat, Joke I.
author_facet Laging, Mirjam
Kal-van Gestel, Judith A.
Weimar, Willem
Roodnat, Joke I.
author_sort Laging, Mirjam
collection PubMed
description Age criteria for kidney transplantation have been liberalized over the years resulting in more waitlisted elderly patients. What are the prospects of elderly patients on the waiting list? METHODS. Between 2000 and 2013, 2622 patients had been waitlisted. Waiting time was defined as the period between dialysis onset and being delisted. Patients were categorized according to age upon listing: <25; 25–44; 45–54; 55–64; and >64 years. Furthermore, the influence of ABO blood type and panel reactive antibodies on outflow patterns was studied. RESULTS. At the end of observation (November 2017), 1957 (75%) patients had been transplanted, 333 (13%) had been delisted without a transplantation, 271 (10%) had died, and 61 (2%) were still waiting. When comparing the age categories, outflow patterns were completely different. The percentage of patients transplanted decreased with increasing age, while the percentage of patients that had been delisted or had died increased with increasing age, especially in the population without living donor. Within 6 years, 93% of the population <25 years had received a (primarily living) donor kidney. In the populations >55 years, 39% received a living donor kidney, while >50% of patients without a living donor had been delisted/died. Multivariable analysis showed that the influence of age, ABO blood type, and panel reactive antibodies on outflow patterns was significant, but the magnitude of the influence of the latter 2 was only modest compared with that of age. CONCLUSIONS. “Elderly” (not only >64 y but even 55–64 y) received a living donor kidney transplantation less often. Moreover, they cannot bear the waiting time for a deceased donor kidney, resulting in delisting without a transplant in more than half the population of patients without a living donor. Promoting living donor kidney transplantation is the only modification that improves transplantation and decreases delisting/death on the waiting list in this population.
format Online
Article
Text
id pubmed-6791595
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-67915952019-11-13 Living Donor Kidney Transplantation Should Be Promoted Among “Elderly” Patients Laging, Mirjam Kal-van Gestel, Judith A. Weimar, Willem Roodnat, Joke I. Transplant Direct Kidney Transplantation Age criteria for kidney transplantation have been liberalized over the years resulting in more waitlisted elderly patients. What are the prospects of elderly patients on the waiting list? METHODS. Between 2000 and 2013, 2622 patients had been waitlisted. Waiting time was defined as the period between dialysis onset and being delisted. Patients were categorized according to age upon listing: <25; 25–44; 45–54; 55–64; and >64 years. Furthermore, the influence of ABO blood type and panel reactive antibodies on outflow patterns was studied. RESULTS. At the end of observation (November 2017), 1957 (75%) patients had been transplanted, 333 (13%) had been delisted without a transplantation, 271 (10%) had died, and 61 (2%) were still waiting. When comparing the age categories, outflow patterns were completely different. The percentage of patients transplanted decreased with increasing age, while the percentage of patients that had been delisted or had died increased with increasing age, especially in the population without living donor. Within 6 years, 93% of the population <25 years had received a (primarily living) donor kidney. In the populations >55 years, 39% received a living donor kidney, while >50% of patients without a living donor had been delisted/died. Multivariable analysis showed that the influence of age, ABO blood type, and panel reactive antibodies on outflow patterns was significant, but the magnitude of the influence of the latter 2 was only modest compared with that of age. CONCLUSIONS. “Elderly” (not only >64 y but even 55–64 y) received a living donor kidney transplantation less often. Moreover, they cannot bear the waiting time for a deceased donor kidney, resulting in delisting without a transplant in more than half the population of patients without a living donor. Promoting living donor kidney transplantation is the only modification that improves transplantation and decreases delisting/death on the waiting list in this population. Wolters Kluwer Health 2019-09-27 /pmc/articles/PMC6791595/ /pubmed/31723590 http://dx.doi.org/10.1097/TXD.0000000000000940 Text en Copyright © 2019 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Kidney Transplantation
Laging, Mirjam
Kal-van Gestel, Judith A.
Weimar, Willem
Roodnat, Joke I.
Living Donor Kidney Transplantation Should Be Promoted Among “Elderly” Patients
title Living Donor Kidney Transplantation Should Be Promoted Among “Elderly” Patients
title_full Living Donor Kidney Transplantation Should Be Promoted Among “Elderly” Patients
title_fullStr Living Donor Kidney Transplantation Should Be Promoted Among “Elderly” Patients
title_full_unstemmed Living Donor Kidney Transplantation Should Be Promoted Among “Elderly” Patients
title_short Living Donor Kidney Transplantation Should Be Promoted Among “Elderly” Patients
title_sort living donor kidney transplantation should be promoted among “elderly” patients
topic Kidney Transplantation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791595/
https://www.ncbi.nlm.nih.gov/pubmed/31723590
http://dx.doi.org/10.1097/TXD.0000000000000940
work_keys_str_mv AT lagingmirjam livingdonorkidneytransplantationshouldbepromotedamongelderlypatients
AT kalvangesteljuditha livingdonorkidneytransplantationshouldbepromotedamongelderlypatients
AT weimarwillem livingdonorkidneytransplantationshouldbepromotedamongelderlypatients
AT roodnatjokei livingdonorkidneytransplantationshouldbepromotedamongelderlypatients